ABPP Assay
The ABPP Assay is a powerful chemical proteomics technique used for the specific labeling, separation, and identification of active enzymes or proteins in complex biological systems. Unlike traditional proteomics methods, the ABPP assay emphasizes not only protein expression levels but also the dynamic detection of protein activity. This technique utilizes small-molecule probes that covalently bind to the active sites of target proteins, enabling highly specific identification of their functional states. The assay is widely employed in disease mechanism analysis, drug target screening, and biomarker discovery.
The principle of the ABPP assay involves the use of Activity-Based Probes (ABPs), which are typically composed of three parts: a recognition group that targets a specific protein, a detectable reporter group (such as a fluorophore or biotin), and a reactive group that covalently binds to the protein's active site. Once the probe binds to the target protein, the labeled proteins are detected using techniques such as fluorescence imaging, electrophoresis, or mass spectrometry. This approach enables selective labeling and quantitative analysis of active proteins in complex biological samples.
Key steps in the ABPP assay include the design and synthesis of specific probes that interact with the active sites of particular protein types, such as proteases, phosphatases, or kinases, without disrupting their natural function. The probes are incubated with biological samples, where they bind to target proteins. Afterward, labeled proteins are separated and enriched using techniques like gel electrophoresis, fluorescence imaging, or affinity purification. The final identification and quantification of these proteins are performed via mass spectrometry.
The major advantage of the ABPP assay lies in its ability to specifically detect protein activity states, making it particularly valuable in drug screening and biomarker discovery. In drug development, the ABPP assay can be used to evaluate the effect of drug molecules on the activity of target proteins, aiding in drug structure optimization and improving specificity and efficacy.
In disease research, the ABPP assay is widely used to explore the mechanisms of tumors, neurodegenerative diseases, and infectious diseases. For instance, in cancer research, ABPP can identify and quantify elevated protease activity in tumor cells, revealing key insights into tumor initiation and progression. In neurodegenerative diseases, the assay can detect enzyme activity changes linked to disease progression, offering potential for early diagnostics and therapeutic target discovery.
Compared to traditional proteomics methods, ABPP offers several distinct advantages. It allows for the real-time detection of protein activity states, rather than simply protein expression levels. The high specificity of the probes provides strong resistance to interference in complex samples, minimizing background noise. Combined with high-resolution mass spectrometry, ABPP provides highly accurate data on protein activity, significantly enhancing detection sensitivity. However, challenges remain, such as the complexity of probe design and synthesis, which requires advanced chemical and biological knowledge. Additionally, probe targeting and affinity can impact the reliability of results, and detecting low-abundance active proteins requires further optimization of sample preparation and signal enrichment techniques.
At MtoZ Biolabs, we leverage our extensive technical expertise and project experience to provide comprehensive analytical services for research institutions and pharmaceutical companies. Whether in drug screening, biomarker discovery, or environmental science, MtoZ Biolabs is dedicated to being your trusted partner, driving the ongoing advancement of scientific research.
MtoZ Biolabs, an integrated chromatography and mass spectrometry (MS) services provider.
Related Services
How to order?
